1.60
-0.19(-10.61%)
Currency In USD
| Previous Close | 1.79 |
| Open | 1.74 |
| Day High | 1.78 |
| Day Low | 1.4 |
| 52-Week High | 106.08 |
| 52-Week Low | 1.1 |
| Volume | 906,845 |
| Average Volume | 386,803 |
| Market Cap | 1.16M |
| PE | -0.03 |
| EPS | -55.19 |
| Moving Average 50 Days | 4.01 |
| Moving Average 200 Days | 9.41 |
| Change | -0.19 |
If you invested $1000 in GRI Bio, Inc. (GRI) since IPO date, it would be worth $0 as of May 09, 2025 at a share price of $1.6. Whereas If you bought $1000 worth of GRI Bio, Inc. (GRI) shares 3 years ago, it would be worth $0.03 as of May 09, 2025 at a share price of $1.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire Inc.
Yesterday at 12:45 PM GMT
The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no safety concerns seen in the data reviewed Continued momentum with completed patient enrollment for the 6-week interim analysis (N=24) an
GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire Inc.
May 07, 2025 1:15 PM GMT
Enrollment completed for the 6-week interim analysis with 24 of the 36 planned patients now enrolled Company on track to report interim biomarker data from the first 12 patients imminently Completion of patient enrollment and topline results expecte
GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference
GlobeNewswire Inc.
Apr 16, 2025 12:35 PM GMT
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibro